-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CHS-114 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CHS-114 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CHS-114 in Solid Tumor Drug Details: CHS-114 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CHS-114 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CHS-114 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CHS-114 in Head And Neck Squamous...
-
Thematic Analysis
NewFoodservices M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Foodservice Sector
-
Product Insights
NewTheradaptive Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Theradaptive Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Theradaptive Inc (Theradaptive) is a biotechnology company that discovers and develops regenerative therapeutics for vascular, soft tissue, and orthopedic repair. It is investigating SF-105 program against spinal fusion; TR-100 to treat long-bone repair; and CH-101 targeting osteochondral repair. The company is also evaluating ORB-TR against long-bone repair; and ORB-SF for posterior lumbar fusion (PLF). Theradaptive utilizes its protein engineering technology...
-
Thematic Analysis
NewCybersecurity in Agriculture – Thematic Intelligence
Cybersecurity in Agriculture Thematic Report Overview Agricultural companies are increasingly adopting technological solutions to combat labor shortages, improve productivity, and address several other challenges. Integration of artificial intelligence (AI), robotics, and the Internet of Things (IoT) has become so widespread that it has become broadly known as the fourth agricultural revolution. However, this increased digitalization of the agriculture sector is creating more cybersecurity vulnerabilities. In this scenario, companies should invest in cybersecurity measures across all stages of the agricultural supply...
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ChapAte in Hemophilia A (Factor VIII Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ChapAte in Hemophilia A (Factor VIII Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ChapAte in Hemophilia A (Factor VIII Deficiency) Drug Details:...
-
Product Insights
CH Sabanas
CH Sabanas is a Hydro project located in Antioquia, Colombia. The project is owned and being developed by W.E. Energia Limpia SAS. The project is at the permitting stage. Empower your strategies with our CH Sabanas report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Sector Analysis
Malaysia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Malaysia Construction Market Overview The Malaysia construction market size was $30.1 billion in 2023. The market will achieve an AAGR of more than 5% during 2025-2028. The following are some of the key highlights of the Malaysian construction market: Investments in leisure and hospitality infrastructure; manufacturing facilities and roads; and renewable energy projects drive the construction market in the country. The infrastructure construction sector accounted for the highest share of the Malaysian construction market in 2023. China Railway Engineering Group...
-
Sector Analysis
Thailand Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Thailand Construction Market Report Overview The Thailand construction market size was $25.3 billion in 2023. The market will achieve an AAGR of more than 4% during 2025-2028. The following are some of the key highlights of the Thailand construction market: The government’s focus on the development of tourism infrastructure, energy generation, and housing projects will fuel the market growth during the forecast period. The residential construction sector accounted for the highest market share in the Thailand construction market in 2023....